You are here

Clinical Trials: Vascular Disease

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, October 20, 2011 - 12:00
Condition:   Myocardial Infarction
Intervention:   Biological: CAP-1002 Allogeneic Cardiosphere-Derived Cells
Sponsors:   Capricor Inc.;   National Institutes of Health (NIH);   National Heart, Lung, and Blood Institute (NHLBI);   California Institute for Regenerative Medicine (CIRM)
Recruiting - verified March 2016
Posted: Monday, October 3, 2011 - 12:00
Condition:   Stroke
Intervention:   Procedure: Harvesting and Isolation of Stem Cells
Sponsors:   Ageless Regenerative Institute;   Instituto de Medicina Regenerativa, S.A. de C.V.
Not yet recruiting - verified October 2013
Posted: Friday, September 23, 2011 - 12:00
Conditions:   Critical Limb Ischemia;   Peripheral Arterial Disease;   Buerger's Disease
Interventions:   Device: ResQ processed bone marrow sample;   Device: Ficoll conventional cell processing method
Sponsors:   Xuanwu Hospital, Beijing;   Thermogenesis Corp.;   Hebei Medical University
Not yet recruiting - verified October 2011
Posted: Wednesday, September 21, 2011 - 12:00
Condition:   Acute Stroke
Interventions:   Drug: Donepezil;   Drug: Placebo
Sponsors:   Imperial College London;   International Stem Cell Forum
Not yet recruiting - verified September 2011
Posted: Wednesday, September 7, 2011 - 12:00
Conditions:   Ischemic Stroke;   Ischaemic Cerebral Infarction;   Infarction, Middle Cerebral Artery;   Ischemia;   Brain Ischemia
Intervention:   Procedure: Intercerebral implantation of allogenic CD34+ stem cell
Sponsor:   China Medical University Hospital
Not yet recruiting - verified December 2011
Posted: Monday, August 1, 2011 - 12:00
Condition:   Peripheral Arterial Disease
Interventions:   Behavioral: Supervised Treadmill Exercise Therapy;   Other: Health education sessions (Control);   Drug: granulocyte macrophage colony stimulating factor (GM-CSF)
Sponsors:   Northwestern University;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified May 2016
Posted: Saturday, July 16, 2011 - 12:00
Condition:   Acute Myocardial Infarction
Interventions:   Other: Autologous Bone marrow mononuclear cells;   Other: Placebo control
Sponsors:   TotipotentRX Cell Therapy Pvt. Ltd.;   TotipotentRX Corporation
Not yet recruiting - verified September 2013
Posted: Friday, July 8, 2011 - 12:00
Conditions:   Acute Myocardial Infarction;   Heart Failure
Intervention:   Procedure: PCI and Stem Cells or Placebo injections
Sponsor:   Meshalkin Research Institute of Pathology of Circulation
Recruiting - verified September 2015
Posted: Monday, May 2, 2011 - 12:00
Conditions:   Scleroderma, Systemic;   Scleroderma, Diffuse;   Scleroderma, Limited;   Raynaud Phenomenon
Interventions:   Drug: Sildenafil citrate;   Drug: Placebo
Sponsors:   Federal University of São Paulo;   Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting - verified April 2011
Posted: Monday, January 31, 2011 - 12:00
Conditions:   Infarction, Middle Cerebral Artery;   Ischemic Stroke,;   Stroke With Hemiparesis,;   Thromboembolic Stroke.
Intervention:   Procedure: Olfactory ensheathing cells
Sponsor:   China Medical University Hospital
Recruiting - verified September 2011

Pages